Acadia Pharmaceuticals

ACAD

29.18

-0.79

-2.6%

After Hours:

29.18

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 30.65
Prev. Close: 29.97
Low/Hi: 28.95 - 30.75
52-Week: 24.31 - 41.20
Volumes
Equity: 1,566,259
90-Day Avg: 1,533,125
Option: 1,323
90-Day Avg: 1,822
Volatility
Todays Stock Vol: 79.6
20-Day (HV): 44.6
52-Week (HV): 43.8
30-Day IV: 51.3 +4.0
IV Pct Rank: 0% Subdued
Fundamental
Div. Yield:
Earnings: 1-Mar (Est.)
P/E Ratio:
Market Cap: 3.7 B
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ACAD Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Cash and Cash Equivalents 112,616 143,789 157,383 163,620
Short Term Investments 254,009 273,531 312,098 365,416
Investments - - - -
Accounts Receivable 15,254 12,378 9,519 7,140
Inventory 5,536 6,003 3,881 4,175
Loans - - - -
Prepaid Expenses 14,557 8,044 6,872 7,546
Net Property Plant and Equipment 2,991 3,296 3,471 3,081
Other Current Assets 0 0 0 0
Current Assets 401,972 443,745 489,753 547,897
Goodwill and Intangibles 5,907 6,277 6,646 7,015
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 413,714 456,315 503,013 561,153
Short Term Debt 0 0 0 0
Other Non-Current Assets 2,844 2,997 3,143 3,160
Accounts Payable 2,962 3,588 2,166 3,912
Accrued Liabilities and Other Payables 33,181 37,325 38,967 36,029
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 36,388 41,175 45,489 42,742
Other Current Liabilities 0 0 4,132 2,644
Accumulated Other Comprehensive Income -73 -97 94 106
Preferred Stock 0 0 0 0
Current Liabilities 36,143 40,913 45,265 42,585
Common Stock 12 12 12 12
Other Non-Current Liabilities 245 262 224 157
Additional Paid-In Capital 1,532,188 1,504,778 1,479,530 1,452,272
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -1,154,801 -1,089,553 -1,022,112 -933,979
Total Equity 377,326 415,140 457,524 518,411
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 163,620 102,138 61,854 11,707
Short Term Investments 365,416 112,994 260,632 174,083
Investments - - - -
Accounts Receivable 7,140 1,638 964 0
Inventory 4,175 0 0 0
Loans - - - -
Prepaid Expenses 7,546 2,219 1,168 2,570
Net Property Plant and Equipment 3,081 2,203 553 579
Other Current Assets 0 0 0 0
Current Assets 547,897 218,989 324,618 188,360
Goodwill and Intangibles 7,015 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 561,153 221,896 325,458 189,118
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,160 704 287 179
Accounts Payable 3,912 1,672 2,016 372
Accrued Liabilities and Other Payables 36,029 20,230 13,818 6,552
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 42,742 22,134 15,969 6,987
Other Current Liabilities 2,644 0 0 55
Accumulated Other Comprehensive Income 106 11 -9 48
Preferred Stock 0 0 0 0
Current Liabilities 42,585 21,902 15,834 6,979
Common Stock 12 10 10 9
Other Non-Current Liabilities 157 232 135 8
Additional Paid-In Capital 1,452,272 862,327 807,631 587,742
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -933,979 -662,586 -498,143 -405,668
Total Equity 518,411 199,762 309,489 182,131

Wait, Before You Leave...